Identification of molecular pathology of asthma and COPD exacerbations

Identification of molecular pathology of asthma and COPD exacerbations - Identification of molecular pathology of asthma and COPD exacerbations

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032507

Enrollment

150

Registered

2018-05-08

Start date

2018-05-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma COPD

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Clinical diagnosis of asthma and/or COPD

Exclusion criteria

Exclusion criteria: Patients who have received anticancer agents within the last 6 months Patients undergoing immunosuppressive therapy with steroids such as in diseases other than asthma or COPD

Design outcomes

Primary

Measure	Time frame
Sputum differential cell counts	—

Secondary

Measure	Time frame
Sputum cytokine levels Cell-free plasma DNA concentration Gene expression levels in sputum cells	—

Countries

Japan

Contacts

Public ContactKeita Hirai

Shizuoka General Hospital Laboratory of Clinical Pharmacogenomics

hiraik@u-shizuoka-ken.ac.jp81-54-247-6111

Outcome results